# U.S. Biomaterials: portfolio, investments and team

> U.S. Biomaterials is a growth equity. 1 investment on record, latest Jan 2008. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/u-s-biomaterials (Millionrounds; every figure on the page links to its filing or article)

[Investor](https://millionrounds.com/investors)

# U.S. Biomaterials

Last cheque observed Jan 2008. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet Growth equity

Series C Biotechnology Education Health Care

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 1 on record

Since the last cheque **6860** days **00** hrs **00** min **00** sec

Median round **$2.5M** Rounds led **0 of 1** Exits **1 from the portfolio**

Pitch U.S. Biomaterials

## U.S. Biomaterials highlights

- 01 1 rounds on record
- 02 Mostly Series C: 100% of its rounds
- 03 1 exits from the portfolio

## What they do

- **Type:** Growth equity (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Biotechnology Education Health Care
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **1 appearances**

- **2008** 1 round
- **Jan** **[NovaMin Technology](https://millionrounds.com/company/novamin-technology)** Series C · US **$2.5M** With 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## Exits from the portfolio

Companies it backed that were later bought or listed **1 in all**

**[NovaMin Technology](https://millionrounds.com/company/novamin-technology)** Bought by [GlaxoSmithKline](https://millionrounds.com/fund/glaxosmithkline) **Undisclosed** May 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Series C

Median round joined **$2.5M** the round, not its cheque

Led 0 of 1 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Jan 2008
- **Exits:** 1 from the portfolio

Rounds by stage said on their site

- Series C *1*

**Pitching U.S. Biomaterials?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Quick answers about U.S. Biomaterials

### What does U.S. Biomaterials invest in?

U.S. Biomaterials invests most often at Series C (100% of the rounds on record), in sectors such as Biotechnology, Education and Health Care.

### How active is U.S. Biomaterials?

1 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2008.

### How big are U.S. Biomaterials's cheques?

The median round it joins is $2.5M.

### Is U.S. Biomaterials investing now?

No investments in the last 12 months; the latest was in Jan 2008.

### What kind of investor is U.S. Biomaterials?

U.S. Biomaterials is a growth equity firm.

### When was U.S. Biomaterials founded?

U.S. Biomaterials was founded in 1974.

### Where does this information on U.S. Biomaterials come from?

From public registers and its own website, checked and rebuilt every night.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=u-s-biomaterials) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=u-s-biomaterials)